Literature DB >> 17329379

Are the GFRUP's recommendations for withholding or withdrawing treatments in critically ill children applicable? Results of a two-year survey.

R Cremer1, A Binoche, O Noizet, C Fourier, S Leteurtre, G Moutel, F Leclerc.   

Abstract

OBJECTIVE: To evaluate feasibility of the guidelines of the Groupe Francophone de Réanimation et Urgence Pédiatriques (French-speaking group of paediatric intensive and emergency care; GFRUP) for limitation of treatments in the paediatric intensive care unit (PICU).
DESIGN: A 2-year prospective survey.
SETTING: A 12-bed PICU at the Hôpital Jeanne de Flandre, Lille, France. PATIENTS: Were included when limitation of treatments was expected.
RESULTS: Of 967 children admitted, 55 were included with a 2-day median delay. They were younger than others (24 v 60 months), had a higher paediatric risk of mortality (PRISM) score (14 v 4), and a higher paediatric overall performance category (POPC) score at admission (2 v 1); all p<0.002. 34 (50% of total deaths) children died. A limitation decision was made without meeting for 7 children who died: 6 received do-not-resuscitate orders (DNROs) and 1 received withholding decision. Decision-making meetings were organised for 31 children, and the following decisions were made: 12 DNROs (6 deaths and 6 survivals), 4 withholding (1 death and 3 survivals), with 14 withdrawing (14 deaths) and 1 continuing treatment (survival). After limitation, 21 (31% of total deaths) children died and 10 survived (POPC score 4). 13 procedures were interrupted because of death and 11 because of clinical improvement (POPC score 4). Parents' opinions were obtained after 4 family conferences (for a total of 110 min), 3 days after inclusion. The first meeting was planned for 6 days after inclusion and held on the 7th day after inclusion; 80% of parents were immediately informed of the decision, which was implemented after half a day.
CONCLUSIONS: GFRUPs procedure was applicable in most cases. The main difficulties were anticipating the correct date for the meeting and involving nurses in the procedure. Children for whom the procedure was interrupted because of clinical improvement and who survived in poor condition without a formal decision pointed out the need for medical criteria for questioning, which should systematically lead to a formal decision-making process.

Entities:  

Mesh:

Year:  2007        PMID: 17329379      PMCID: PMC2598266          DOI: 10.1136/jme.2006.015990

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  20 in total

1.  Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine.

Authors:  R D Truog; A F Cist; S E Brackett; J P Burns; M A Curley; M Danis; M A DeVita; S H Rosenbaum; D M Rothenberg; C L Sprung; S A Webb; G S Wlody; W E Hurford
Journal:  Crit Care Med       Date:  2001-12       Impact factor: 7.598

2.  Forgoing life support across borders: who decides and why?

Authors:  Joel E Frader
Journal:  Pediatr Crit Care Med       Date:  2004-05       Impact factor: 3.624

3.  Toward an ethics of communication among countries.

Authors:  Denis J Devictor
Journal:  Pediatr Crit Care Med       Date:  2004-05       Impact factor: 3.624

4.  Pediatric risk of mortality (PRISM) score.

Authors:  M M Pollack; U E Ruttimann; P R Getson
Journal:  Crit Care Med       Date:  1988-11       Impact factor: 7.598

5.  American Academy of Pediatrics Committee on Bioethics: Guidelines on foregoing life-sustaining medical treatment.

Authors: 
Journal:  Pediatrics       Date:  1994-03       Impact factor: 7.124

6.  Assessing the outcome of pediatric intensive care.

Authors:  D H Fiser
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406

7.  Circumstances of dying in hospitalized children.

Authors:  M E van der Wal; L N Renfurm; A J van Vught; R J Gemke
Journal:  Eur J Pediatr       Date:  1999-07       Impact factor: 3.183

Review 8.  Ethics and the care of critically ill infants and children. American Academy of Pediatrics Committee on Bioethics.

Authors: 
Journal:  Pediatrics       Date:  1996-07       Impact factor: 7.124

9.  No resuscitation orders and withdrawal of therapy in French paediatric intensive care units. Groupe Francophone de Réanimation et d'Urgences Pédiatriques.

Authors:  A Martinot; B Grandbastien; S Leteurtre; A Duhamel; F Leclerc
Journal:  Acta Paediatr       Date:  1998-07       Impact factor: 2.299

10.  Dying in the intensive care unit: collaborative multicenter study about forgoing life-sustaining treatment in Argentine pediatric intensive care units.

Authors:  María Althabe; Gustavo Cardigni; Juan C Vassallo; Daniel Allende; Mabel Berrueta; Marcela Codermatz; Juan Córdoba; Silvia Castellano; Roberto Jabornisky; Yolanda Marrone; Maria C Orsi; Gabriela Rodriguez; Juan Varón; Eduardo Schnitzler; Héctor Tamusch; José M Torres; Laura Vega
Journal:  Pediatr Crit Care Med       Date:  2003-04       Impact factor: 3.624

View more
  4 in total

1.  Forgoing life support: how the decision is made in European pediatric intensive care units.

Authors:  Denis J Devictor; Jos M Latour
Journal:  Intensive Care Med       Date:  2011-10-01       Impact factor: 17.440

2.  The outcome of treatment limitation discussions in newborns with brain injury.

Authors:  Marcus Brecht; Dominic J C Wilkinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2014-12-04       Impact factor: 5.747

3.  [Mortality pattern in children aged 3-59 months hospitalized in the Intensive Care Unit at a Paediatric Center in Yaounde-Cameroon].

Authors:  Félicitée Nguefack; Evelyn Mah; Mina Ntoto Kinkela; Thierry Tagne; David Chelo; Roger Dongmo; Paul Koki Ndombo
Journal:  Pan Afr Med J       Date:  2020-08-05

4.  How doctors actually (do not) involve families in decisions to continue or discontinue life-sustaining treatment in neonatal, pediatric, and adult intensive care: A qualitative study.

Authors:  A Aranka Akkermans; J M W J Joyce Lamerichs; M J Marcus Schultz; T G V Thomas Cherpanath; J B M Job van Woensel; M Marc van Heerde; A H L C Anton van Kaam; M D Moniek van de Loo; A M Anne Stiggelbout; E M A Ellen Smets; M A Mirjam de Vos
Journal:  Palliat Med       Date:  2021-06-28       Impact factor: 4.762

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.